Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for pemetrexed effectiveness and safety
NL-OMON39476Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pemetrexed in non-small cell lung cancer (NSCLC) and pleural mesothelioma, sponsored by Erasmus MC. Started Oct 2012; status: recruiting.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)pleural mesothelioma
Beyond the preview
Go deeper on NL-OMON39476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39476.